Month: January 2022

Categories
Pharmaceutical

Tumor Embolization Market To Reflect Impressive Growth Rate During 2021-2031

Market Overview

Tumor embolization is a minimally invasive procedure performed few days prior to a planned surgical removal of a tumor. Certain tumors that occur in the brain, neck and spine usually have a large blood supply which makes the surgical resection challenging and risky due to the likelihood of excessive blood loss. Tumor embolization can be used for cancerous and benign tumors as well.

Tumor embolization procedure involves blood vessel mapping followed by insertion of tiny catheters into an artery close to the target tumor and then an agent is released which blocks the artery on the site and shutdowns the blood flow to the tumor. Tumor embolization could be used either to stop the prominent blood supply or to treat the tumor on site as well.

Request Sample   https://www.factmr.com/connectus/sample?flag=S&rep_id=3997

Tumor Embolization Market: Drivers and Restraints

Owing to the aid provided by tumor embolization to the patients and providing oncologists or surgeons the ability to treat the tumor effectively and conveniently, the tumor embolization market is expected to harness the major share in the interventional oncology sector. Global tumor embolization market is expected to escalate in the forecast period due to increasing preference for minimally invasive treatment procedures, growing prevalence of cancer, rising hospitals establishments, and technological progress in the field of oncology. Tumor embolization is remarkably effective procedure. However, due to lack of advanced hospital, surgical center establishments and lack of experienced professionals sometime may result in failure of blocking agents and might incur infection which could slow down the market for tumor embolization.

Request Customization https://www.factmr.com/connectus/sample?flag=RC&rep_id=3997

Tumor Embolization Market: Segmentation

Tentatively, the global tumor embolization market can be segmented on the basis of the product, by indication, by end user, and by geography.

Based on the product type, the global tumor embolization market is segmented as:

  • NBCA glue
  • Microspheres or microbeads
  • Microcoils

Based on the indication, the global tumor embolization market is segmented as:

  • Hemangioblastoma
  • Juvenile nasal angiofibroma
  • Meningioma
  • Aneurysmal bone cyst
  • Paraganglioma
  • Hemangiopericytoma
  • others

Based on the end-user, the global tumor embolization market is segmented as:

  • Hospitals
  • Intensive Care Units
  • Surgical Centers
  • Cancer Treatment Centers

 Request ToC   https://www.factmr.com/connectus/sample?flag=T&rep_id=3997

Tumor Embolization Market: Overview

Tumor embolization market is vastly divided on the basis of type of cancer like Hemangioblastoma, Juvenile nasal angiofibroma, Meningioma and others. Based on the embolization or blocking agent the tumor embolization market could be shared into NBCA glue, microspheres or microbeads, and microcoils. The tumor embolization market is highly driven by the increasing number of cancer patients and rising awareness about benefits of tumor embolization technique. Moreover, advancements in the tumor embolization agents, for instance, mixing of microbeads with radioactive isotopes or inducing a chemotherapeutic substances to kill the cancerous tumor on site is anticipated to witness a huge growth in foreseen future, consequently, benefiting and increasing the tumor embolization market globally.

Tumor Embolization Market: Region-wise Outlook

Owing to the presence of developed economies, the U.S. and Canada, North America is anticipated to prevail in the market for tumor embolization over the estimated time period. Additionally, the presence of developed healthcare facilities and advanced infrastructure, growing prevalence of oncogenic and non-oncogenic tumors coupled with the growing need for minimally invasive interventional techniques are expected to burgeoning the tumor embolization market in the forecasted period. Europe in the second position is estimated to closely follow North America.

The Asia Pacific regional market for tumor embolization is anticipated to grow at the highest rate after North America and Europe. Emerging economies, such as India, China, and South Korea along with Oceania region are expected to witness high-growth opportunities for tumor embolization market players, owing to the prevailing demand of minimally invasive and highly effective interventional oncology techniques.

Tumor Embolization Market: Key Market Players

Some of the key market players operating in the tumor embolization market are: MicroVention Inc., Kaneka Pharma Europe NV German Branch, Penumbra, Inc, DePuy Synthes 2014-2019, Cook 2019, ab medica Deutschland GmbH & Co. KG, Boston Scientific Corporation, Balt Extrusion, AngioDynamics and others.

The report on tumor embolization is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report on tumor embolization provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report on tumor embolization also maps the qualitative impact of various market factors on market segments and geographies.

For More Insights- https://www.biospace.com/article/anti-snoring-treatment-has-become-highly-sought-after-to-curb-rising-cases-of-sleep-apnea-fact-mr/

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner. 

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Digital Migraine Treatment Device Market To Receive Overwhelming Hike In Revenues By 2031

Market Overview

The occurrence of spasmodic headache is termed as a medical condition called as migraine. The onset of migraine is generally experienced by approximately 15% of the world population. The symptoms include mild to severe headache and issues pertaining sensitivity to light and sound. The expensive dependence on pharmaceutical drugs and therapies which are invasive, impeding with the implants, causing overuse and associated side effects.

While the current treatments include triptans and ergots patients are shifting towards more specific digital migraine treatment devices. Neuromodulation is primarily the technology driving the patients towards the growth of the digital migraine treatment devices. The USFDA gave de novo clearance to Thranica’s Nevirio Migra, a smartphone connected device giving other manufacturers an aspiration to enter the untapped markets.

Click here To get a Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=3995

Neuromodulation is primarily the technology driving the patients towards the growth of the digital migraine treatment devices. The USFDA gave de novo clearance to Thranica’s Nevirio Migra, a smartphone connected device giving other manufacturers an aspiration to enter the untapped markets.

Digital Migraine Treatment Device Market: Drivers and Restraints

The increasing prevalence of migraine and increasing level of awareness in target patient population is one of the most important factors responsible for the growth of digital migraine treatment devices market. Increasing geriatric population is also expected to increase the growth of digital migraine treatment devices market.

Disruptive technologies happen to exist with the changing trends and it is evident from the clinical trials and volunteer feedback that the digital migraine treatment devices being less invasive is likely to increase the acceptance. The efficacy and drug-free nature makes the reliability one of the pluses that is expected to drive the growth of digital migraine treatment devices.

The unmet needs coupled with novel technology based device is expected to amplify manufacturing of digital migraine treatment devices. The de novo pathway sanctioned by the USFDA to speedily make the digital migraine treatment devices available in the market is anticipated for the entry of new players who were already working on the neuromodulation based digital migraine treatment devices.

Digital Migraine Treatment Device Market: Segmentation

Tentatively, the global Digital Migraine Treatment Devices market can be segmented on the basis of the technology, end user, and geography.

Based on the technology, the global digital migraine treatment devices market is segmented as:

  • Supraorbital stimulation digital migraine treatment devices
  • Vagus nerve stimulation digital migraine treatment devices (VNS)
  • Single-pulse transcranial magnetic stimulation digital migraine treatment devices (sTMS)
  • Occipital nerve stimulation digital migraine treatment devices (ONS)

Based on end user, the global digital migraine treatment devices market is segmented as:

  • Hospitals
  • Specialty Clinics
  • Pharmacies

Navigate here to get a TOC of the Report @ https://www.factmr.com/connectus/sample?flag=T&rep_id=3995

Digital Migraine Treatment Device Market: Overview

Based on the technology utilized, the digital migraine treatment devices have been segmented into supraorbital stimulation digital migraine treatment devices, Vagus nerve stimulation (VNS) digital migraine treatment devices, single-pulse transcranial magnetic stimulation digital migraine treatment devices and occipital nerve stimulation digital migraine treatment devices.

Supraorbital stimulation digital migraine treatment devices are expected to hold the maximum revenue share in the digital migraine treatment devices market. Based on the end user, the digital migraine treatment devices market has been segmented into hospitals, specialty clinics and pharmacies. Hospitals are expected to hold the maximum revenue share in the digital migraine treatment devices market.

Digital Migraine Treatment Device Market: Regional Outlook

Geographically, the global digital migraine treatment devices market is segmented into seven regions viz. North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA. North America is expected to be a dominant market in the global digital migraine treatment devices market because of the presence of well-established healthcare infrastructure and availability of advanced healthcare facilities.

The Asia Pacific is expected to hold a significant growth rate of digital migraine treatment devices market. The digital migraine treatment devices market in the Asia Pacific is expected to grow at a significant CAGR due to the presence of a large population. Europe is also expected to hold a large revenue share in the digital migraine treatment devices market owing to the increasing R&D funding and increasing healthcare awareness.

Digital Migraine Treatment Devices Market: Key Players

There are few key players operating in the digital migraine treatment devices market like Theranica Bio-Electronics LTD, electroCore, Inc., Cirrus Healthcare Products, Cefaly Technology, eNeura Inc., Prolivio and Neuros Medical.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

For More Insights- https://www.biospace.com/article/increasing-prevalence-of-diabetic-foot-ulcers-will-bolster-demand-for-contact-cast-systems-fact-mr/

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Volumetric Arc Therapy Market To Witness Robust Expansion Throughout The Forecast Period 2021 –2031

 

Market Overview

In 2007, volumetric arc therapy was first introduced. Volumetric arc therapy was considered to be a novel radiation technique which allows the instantaneous variation of 3 parameters during treatment delivery such as treatment aperture shape via movement of moving multileaf collimators leaves, gantry rotation speed, and dose rate.

The traditional form of arc therapy called intensity modulated arc therapy using multiple superimposed arcs to attain a satisfactory dose distribution. With the development of volumetric arc therapy techniques which allows the complete target volume to be treated using 1 or 2 arcs. Based on recent studies, volumetric arc therapy is basically designed as a single arc intensity therapy technique that works dose rate variation. The volumetric arc therapy benefits as compared to tomotherapy is the delivery of treatment possibility on conventional linear accelerators.

Request Sample   https://www.factmr.com/connectus/sample?flag=S&rep_id=3993

Volumetric Arc Therapy Market: Drivers and Restraints

The main advantages of volumetric arc therapy are speed and precision. Volumetric arc therapy mainly focuses on the radiation applied to the tumor and protect the healthy tissues. The time duration required for each volumetric arc therapy treatment is less than two minutes. This factor is responsible for growing the market growth of volumetric arc therapy market. Moreover, faster treatments improve the precision of radiation delivery and patient convenience. However, volumetric arc therapy potentially increases the risk of secondary malignancy due to low dose radiation surrounding normal tissue which may hamper the market growth of volumetric arc therapy market. Due to this volumetric arc therapy cannot be considered as the universal solution for all clinical circumstances.

Volumetric Arc Therapy Market: Segmentation

The global volumetric arc therapy market can be segmented on the basis of indications, end user and geography.

Request Customization https://www.factmr.com/connectus/sample?flag=RC&rep_id=3993

Based on indications, the global volumetric arc therapy market is segmented as:

  • Prostate cancer
  • Pelvic malignancies
    • Anal cancer
    • Rectal cancer
    • Gynaecological cancer
  • Head and neck cancer
  • Thoracic tumours
  • Lung cancer
  • Mesothelioma
  • Central nervous system tumours
    • Benign lesions
    • Malignant Glioma
    • Metastatic lesions
  • Breast cancer
  • Lymphoma
  • Intra-abdominal tumours
  • Others

Based on end user, the global volumetric arc therapy market is segmented as:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

Request ToC   https://www.factmr.com/connectus/sample?flag=T&rep_id=3993

Volumetric Arc Therapy Market: Overview

The rising demand for volumetric arc therapy is driven by the increased disposable income and raising awareness for new technologies. The widespread availability of various therapy approaches and the rising number of well-trained healthcare professionals improve patient compliance driving the growth of the volumetric arc therapy market. Various initiatives by non-governmental and government organizations especially in developing regions expected to increase the awareness about the symptoms as well as causative factors of different type of cancer expected to drive the growth of the volumetric arc therapy market.

Volumetric Arc Therapy Market: Regional Outlook

The North America volumetric arc therapy market is expected to accounts for a large market share owing to the rising prevalence of different types of cancer due to change in habits and lifestyle which is growing at a rapid pace. The Europe region is expected to be the prominent market for volumetric arc therapy due to the presence of the advanced healthcare infrastructure. The Asia Pacific region is expected to show the high growth for the volumetric arc therapy market due to raising awareness among the population regarding new technologies. The emerging countries such as India, China, Brazil, and South Africa are expected to show prominent growth in the forecast years and acts as the potential volumetric arc therapy market for the manufacturer.

Volumetric Arc Therapy Market: Key Players

There are only a few key players operating in the global volumetric arc therapy market such as Varian Medical Systems, Koninklijke Philips N.V., and Elekta. This creates a huge market opportunity for the manufacturers who want to enter in this field.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

  • Volumetric Arc Therapy Market Segments
  • Volumetric Arc Therapy Market Dynamics
  • Volumetric Arc Therapy Market Size
  • Market Supply & Demand
  • Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain 

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Russia, Rest of Europe)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, Indonesia, Malaysia, Rest of East Asia)
  • Middle East and Africa (N. Africa, S. Africa, Israel, Rest Of MEA)

For More Insights- https://www.biospace.com/article/rising-incidence-of-strokes-and-spinal-cord-injuries-spurring-the-growth-of-rehabilitation-robots-market-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Improving Treatment Options And Diagnosis Rate Are The Major Factors Expected To Drive The Growth Of The Waldenstrom Macroglobulinemia Treatment Market 2031

Waldenstrom macroglobulinemia is a rare cancer and is characterized by high level of immunoglobulin M (IgM) in the serum, which leads to increased serum viscosity, and presence of a lymphoplasmacytic infiltrate in the bone marrow. Waldenstrom macroglobulinemia starts in B cells or B lymphocytes and leads to excess amount of IgM. Treatment options for Waldenstrom macroglobulinemia vary according to symptoms. In the last few years, medical science has made much progress and a number of new treatments for this type of cancer have been introduced.

Request for a sample here-
https://www.factmr.com/connectus/sample?flag=S&rep_id=2580

Waldenstrom macroglobulinemia Market: Segmentation

The global Waldenstrom macroglobulinemia market can be segmented on the basis of treatment, distribution channel and geography.

Based on treatment, the global Waldenstrom macroglobulinemia market is segmented as:

  • Chemotherapy
    • Alkylating agents
      • Cyclophosphamide (Cytoxan)
      • Bendamustine (Treanda)
    • Purine analogs
      • Fludarabine (Fludara)
      • Cladribine (2-CdA, Leustatin)
    • Corticosteroids
      • Prednisone
      • Dexamethasone (Decadron)
    • Others
      • Vincristine (Oncovin)
      • Doxorubicin (Adriamycin)
    • Targeted Therapy
      • Proteasome Inhibitors (bortezomib, carfilzomib)
      • mTOR inhibitors (Everolimus)
      • Bruton tyrosine kinase (BTK) inhibitors (ibrutinib)
    • Biological/immunotherapy
      • Monoclonal antibodies (rituximab, ofatumumab, alemtuzumab)
      • Immunomodulating Agents (Pomalidomide, Thalidomide)
      • Cytokines (Interfero)
    • Plasmapheresis
    • Stem Cell Transplantation

Based on distribution channel, the global Waldenstrom macroglobulinemia market is segmented as:

  • Hospitals
  • Specialty Cancer Clinics

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=2580

Waldenstrom macroglobulinemia Market: Key Players

Some of the players identified in the global include Baxter International Inc., Teva Pharmaceutical Industries Ltd., Bayer AG, Janssen Pharmaceutica NV (Johnson & Johnson), Merck & Co Inc., Hiospira (Pfizer Inc.), Takeda Pharmaceutical Company Limited., Amgen Inc., Novartis AG and (Genentech) F. Hoffman-La Roche AG, among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

Essential Takeaways from the this Market Report

  • Comparison of prominent players operating in the market.
  • Recent developments and key strategies adopted by key players.
  • Study of the micro and macro-economic growth indicators.
  • Impact of the various factors on the value chain.
  • Evaluation of current NavigaWaldenstrom Macroglobulinemia market size, forecast and technological advancements within the industry.
  • Current Insights influencing the scenario and key trends in NavigaWaldenstrom Macroglobulinemia market.

Enquire Before Buying Here – https://www.factmr.com/connectus/sample?flag=EB&rep_id=2580

The Report Covers Exhaustive Analysis On:

  • NavigaWaldenstrom Macroglobulinemia Market Drivers, Segments and Restraints.
  • NavigaWaldenstrom Macroglobulinemia Market Survey and Dynamics
  • NavigaWaldenstrom Macroglobulinemia Market Size & Demand
  • NavigaWaldenstrom Macroglobulinemia Key Trends/Issues/Challenges
  • NavigaWaldenstrom Macroglobulinemia Sales, Competition & Companies involved

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Osteoporosis Testing Sales Reliant on Surging Cases of Osteopenia: Fact.MR

Award winning market research company Fact.MR is conducting a study on the global osteoporosis testing market for the upcoming decade. As per its findings, the market is poised to witness credible gains across 2021, as the frequency of chronic bone diseases witness an escalating trend. Rising prevalence in different disorders such as rheumatoid arthritis, hyperparathyroidism, chronic kidney disease causing bone loss and osteopenia, providing an impetus to osteoporosis testing.

Request Sample at https://www.factmr.com/connectus/sample?flag=S&rep_id=1219

Osteoporosis testing market: Segmentation

Tentatively, osteoporosis testing market has been segmented on the basis of the component, end user, and geography.

Based on product type, osteoporosis testing market is segmented as below:

  • Dexa-Scan
  • FRAX tool
  • CT scans
  • X-rays
  • Ultrasounds

Based on end user, osteoporosis testing market is segmented as below:

  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Surgical Centers

Osteoporosis testing Market: Key Players

Some of the players identified in the Osteoporosis testing market include GE Healthcare, Merck & Company, B.M.Tech. Worldwide Co. Ltd, DMS Imaging, Swissray, Hologic Inc. Pfizer Inc., CompuMed, Inc., Eli Lilly and Company

Prominent Drivers

  • Fast reversal time and low cost procedure to boost the demand
  • Diverse application of osteoporosis testing procedures in tracking bone density to create growth prospects
  • Increasing cases of osteopenia is increasing bone tissue deterioration, bolstering osteoporosis testing prospects

Key Restraints

  • Lack of awareness between joint pains and osteoporosis and limitation to DEXA to hinder the growth
  • Potential side effects such as nosebleed, blood pressure fluctuations associated with the procedure to hamper the adoption rate

Request more information about Report Customization: https://www.factmr.com/connectus/sample?flag=RC&rep_id=1219

Osteoporosis testing Market: Regional Outlook

Geographically, Osteoporosis testing market is segmented into regions viz. North America, Europe, Asia-Pacific excluding Japan, Middle East and Africa and Japan. North America & Europe region exhibits a healthy growth in terms of revenue due to increased awareness of checking osteoporosis as a part of routine checkup. The lower cost of the procedure compared with other alternative treatment and low risk associated with the procedure is boosting the growth of osteoporosis testing market. The developing cluster of North America, Asia, and Africa region is likely to gain momentum in late 2020. Patient population suffering from osteoporosis testing are mostly prescribed with alternative medicine treatment in the region, which results in chronic side effects due to treatment.

Osteoporosis testing Market: Drivers and Restraints

Growing number of incidence of Osteoporosis are driving the growth of Osteoporosis testing market. Rapid turnaround time, lower cost of procedure over conventional methods also fuel the growth of Osteoporosis testing market. Also, the varied application of Osteoporosis testing procedures in analyzing/tracking bone density and increasing adoption in a routine check of Osteoporosis is harnessing the growth of Osteoporosis testing market. Osteoporosis testing is a technological integration of existing bone densitometer or scanning techniques have further reduced the risk associated with kyphoplasty or vertebroplasty procedures. However, potential side effects associated with the kyphoplasty or vertebroplasty procedures such as nosebleed, fainting, blood pressure fluctuation or reactions due to the anesthesia would hamper the adoption rate. Lack of awareness between joint pain and osteoporosis and limitations of DEXA leads to restrains the osteoporosis testing market.

More Insights on the Osteoporosis testing Market

In its latest report, Fact.MR offers unbiased analysis of the global osteoporosis testing market. The report divulges essential insights on osteoporosis testing market on the basis of product type (dexa-scan, FRAX tool, CT scans, X-rays, Ultrasounds), end-user (hospitals, orthopedics clinic, and ambulatory surgical centers), and regions (North America, Latin America, Europe, Japan, APEJ, and Middle East and Africa)

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Half of Every Dollar Spent on Sponge Detection System is Captured by Radio-frequency Surgical Sponge Detection Systems: Fact.MR

The global sponge detection system market is poised to expand at a CAGR of 4.5% during the forecast period 2021 to 2031. The global demand increases at 5.7% year on year in 2021.

Radiofrequency detection systems will emerge as the top-selling technology in the market. Fact.MR predicts the segment to account for 46% of global sales of sponge detection systems through 2031.

The retained sponges during surgeries cause undesirable impacts on a patient’s health such as fistulas obstructions, bowels, readmission, prolonged hospital stay, reoperation, infection, and sometimes death.

The conventional method of preventing retention of surgical sponges is manual counting umpteen times before and a surgical procedure. This method cannot be completely trusted on because it is time-consuming and prone to human error.

Request Sample : https://www.factmr.com/connectus/sample?flag=S&rep_id=2566

Thus, novel technologies such as radio frequency sponge detection and identification and computer-assisted sponge count devices are highly sought-after to help in the prevention and detection of retained surgical sponges.

Rising cases of errors during emergency surgeries and lack of communication between surgical staff during a surgery might result in accidents. Thus the need for sponge detection systems has increases as healthcare professionals aim at curbing the risk of errors to offer precise patient care.

According to the Centers for Medicare and Medicaid Services (CMS), retained surgical items are knowns as “never events”, and CSM does not reimburse any additional medical care for treating diseases caused by retained surgical sponges. Thus, the sponge detection systems are expected to be very effective and useful during emergency surgeries.

 “Leading players in the global sponge detection systems are investing in developing cost-effective solutions to compete with the alternative options available in the market,” says the Fact.MR analyst.

Key Takeaways from Sponge Detection System Market Survey

  • The Australia market is expected to expand at a CAGR of 4.1% and hold market share of 58.8% in Oceania as the country is witnessing increased spending in healthcare sector.
  • China is likely to lead East Asia market with 47% market share in 2021 and rise at a CAGR of 4.6% through 2031 owing to rising awareness among surgeons and operating room staff about retained surgical sponges’ complications.
  • India will hold a significant share in the South Asia market with market value of US$6mn in 2021 due to large population base and large share of elderly population.
  • The North America market is expected to remain dominant, accounting for 30.1% of global sales.

Key Drivers

  • Government initiatives to ensure improved hospital stay and patient care are bolstering demand for sponge detection systems.
  • Availability of advanced healthcare facilities and continuous medical training to adhere to stringent government regulations is expected to boost sales of sponge detection systems.
  • The error of leaving surgical sponges inside a patient’s body causes pain and suffering. According to the report, in the U.S. alone, around 11 cases of surgical sponges are left inside a patient’s body, this causes the healthcare system an average annual cost of US$2.4bn. Focus on curbing such instances will create opportunities for growth of the market.

Key Restrains

  • The COVID-19 pandemic has resulted in shortage of manpower, research and development activities, commercial production, and lockdowns. This has decreased the sales of sponge detection systems significantly all across the globe.

Enquire Before Buying: https://www.factmr.com/connectus/sample?flag=EB&rep_id=2566

Competitive Landscape

Key players operating in the global sponge detection systems market are focusing on partnerships and acquisitions of smaller companies that are developing advanced sponge detection systems by incorporating radiofrequency. Manufacturers are actively adopting these strategies to expand their product footprint in postoperative surgical care sector.

For instance, Haldor Advanced Technologies Ltd. in 2018 secured a grant for its new key patent that represented continuous commitment to leadership and innovation of the RFID’s surgical items track and trace market in the U.S.

Haldor Advanced Technologies in 2016 installed ORLocate SPD system in hospitals in Sydney and Queensland, NSW.

The key manufacturers in the global sponge detection system market as profiled by Fact.MR are:

  • Stryker Corporation
  • Medtronic plc.
  • Haldor Advanced Technologies

More Valuable Insights on Sponge Detection System Market

Fact.MR, in its new report, offers an unbiased analysis of the global sponge detection system market, analyzing forecast statistics through 2021 and beyond. The survey reveals growth projections in sponge detection system market with detailed segmentation:

Technology

  • Computer-assisted Sponge Count Devices
  • Radiofrequency Sponge Detection Systems
  • Radiofrequency Identification Sponge Detection Systems

Modality

  • Hand-held Sponge Detection Systems
  • Bench Top Sponge Detection Systems

Product Type

  • Sponge Detecting Systems
  • Body Scanners
  • Room Scanners

Application

  • Sponge Detection Systems for Abdominal Surgeries
  • Sponge Detection Systems for General Surgeries
  • Sponge Detection Systems for Gastrointestinal Surgeries
  • Sponge Detection Systems for Cardiac Surgeries
  • Sponge Detection Systems for Gynaecology and Obstetrics Surgeries
  • Sponge Detection Systems for Orthopedic & Arthroscopy
  • Sponge Detection Systems for Neurology

End User

  • Sponge Detection Systems for Hospitals
  • Sponge Detection Systems for Clinics
  • Sponge Detection Systems for Ambulatory Surgical Centers

Regions

  • North America
  • South America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Key Questions Covered in the Sponge Detection System Market Report 

  • The market survey also highlights projected sales growth for sponge detection system market between 2021 and 2031
  • The report offers insight into sponge detection system demand outlook for 2021-2031
  • Sponge detection system market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, collaborations or partnerships, and others
  • Sponge detection system market analysis identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Biotechnology Industry Is Creating Sales Growth Opportunities For Animal Probiotics Market In Near Future

Fact.MR has adopted multi-disciplinary approach to shed light on the Animal Probiotics during the historical period. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year, and key prospects over the forecast period 2020-2028. The insights and analytics on the Animal Probiotics Market span several pages.

Animal probiotics is widely accepted today, and the rapidly advancing technology related to molecular biology and gene sequencing is aiding researchers dig deep to explore novel probiotic applications for animals, such as in consumer-packaged health products and in feed for companion pets. Over time, livestock and cattle farmers have increased the adoption of animal probiotics for commercial animal feed for poultry and cattle to change the gastrointestinal flora, which continues to trigger the sales of animal probiotics, impacting the animal probiotics market in a positive way.

Request a Sample Report containing crucial Graphs and Figures – https://www.factmr.com/connectus/sample?flag=S&rep_id=1067

Animal Probiotics Market: Segmentation
The global animal probiotics market can be segmented on the basis of drug type, distribution channel and geography.

Based on product type, the global animal probiotics market is segmented as:

  • Nutrition Supplements
  • Food Supplements

Based on form type, the global animal probiotics market is segmented as:

  • Dry
  • Liquid

Based on bacteria type, the global animal probiotics market is segmented as:

  • Lactobacillus
  • Thermophiles
  • Streptococcus
  • Bifidobacteria
  • Others

Based on animal type, the global animal probiotics market is segmented as:

  • Companion Animals
    • Cats
    • Dogs
    • Horse
  • Farm Animals
    • Ruminants
    • Swine
    • Poultry

Based on distribution channel, the global animal probiotics market is segmented as:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=1067

After reading the Animal Probiotics Market report, readers get insight into:

  • Major drivers and restraining factors, opportunities and challenges, and the competitive landscape
  • New, promising avenues in key regions
  • New revenue streams for all players in emerging markets
  • Focus and changing role of various regulatory agencies in bolstering new opportunities in various regions
  • Demand and uptake patterns in key industries of the Animal Probiotics Market
  • New research and development projects in new technologies in key regional markets
  • Changing revenue share and size of key product segments during the forecast period 2020-2028.
  • Technologies and business models with disruptive potential

Animal Probiotics Market: Regional Outlook
Geographically, the global animal probiotics market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). Asia Pacific is expected to be the dominant market in the global animal probiotics market owing to the presence of a large number of consumers in this region. Increasing disposable income and increased middle class population are among factors driving the Asia Pacific animal probiotics market. Europe is expected to have a second-largest share in the global animal probiotics market throughout the forecast period due to a ban on the usage of antibiotics that promote the growth of animals, which has boosted the demand for animal probiotics. Middle East and Africa accounts for significant growth owing to the increased demand for meat and meat-related products. North America accounts for moderate growth owing increasing concerns of owners regarding their animals as well as increasing awareness about healthcare.

Animal Probiotics Market: Key Players
The global market for opioid withdrawal treatment is highly fragmented. Some of the key players operating in the global opioid withdrawal treatment market are Mystical Biotech Pvt Ltd., LALLEMAND Inc., ProbioFerm, ProVen Probiotics, Vit-E-Men Company, Vets Plus, Inc, among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Growing Prevalence And Recurrence Is Expected To Drive The Growth Of The Rheumatoid Arthritis Stem Cell Therapy Market

Rheumatoid arthritis stem cell therapy has been demonstrated to induce profound healing activity, halt arthritic conditions, and in many cases, reverse and regenerate joint tissue. Today, bone marrow transplant, adipose or fat-derived stem cells, and allogeneic mesenchymal stem cells (human umbilical cord tissue) are used for rheumatoid arthritis stem cell therapy.

 Request for Sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=1001

Rheumatoid Arthritis Stem Cell Therapy Market: Segmentation

Tentatively, the global rheumatoid arthritis stem cell therapy market can be segmented on the basis of treatment type, application, end user and geography.

Based on treatment type, the global rheumatoid arthritis stem cell therapy market can be segmented into:

  • Allogeneic Mesenchymal stem cells
  • Bone marrow Transplant
  • Adipose Tissue Stem Cells

Based on application, the global rheumatoid arthritis stem cell therapy market can be segmented into:

  • Rheumatoid Arthritis Stem Cell Therapy

Based on distribution channel, the global rheumatoid arthritis stem cell therapy market can be segmented into:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Key questions answered in Rheumatoid Arthritis Stem Cell Therapy Market Survey Report:

  1. What is the current scenario and key trends in Rheumatoid Arthritis Stem Cell Therapy Market?
  2. What are the key strategies companies are adopting to increase their consumer base?
  3. What are the key categories within the Rheumatoid Arthritis Stem Cell Therapy segments and their future potential?
  4. What are the major Rheumatoid Arthritis Stem Cell Therapy Market drivers and their expected impact during the short, medium, and long terms?
  5. What is the Rheumatoid Arthritis Stem Cell Therapy Market size and what are the opportunities for the key players?

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=1001

Rheumatoid Arthritis Stem Cell Therapy Market: Key Players

The global market for rheumatoid arthritis stem cell therapy is highly fragmented. Examples of some of the key players operating in the global rheumatoid arthritis stem cell therapy market include Mesoblast Ltd., Roslin Cells, Regeneus Ltd, ReNeuron Group plc, International Stem Cell Corporation, TiGenix and others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

Rheumatoid Arthritis Stem Cell Therapy Market, Rheumatoid Arthritis Stem Cell Therapy Market report, Rheumatoid Arthritis Stem Cell Therapy Market size, Rheumatoid Arthritis Stem Cell Therapy Market share

Geographically, the global rheumatoid arthritis stem cell therapy market can be segmented into viz. North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the dominant region in the global rheumatoid arthritis stem cell therapy market, owing to the presence of various key players. The rheumatoid arthritis stem cell therapy market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to the expansion of product offerings by key players. Europe is expected to have the second large share in the global rheumatoid arthritis stem cell therapy market throughout the forecast period.

Enquire Before Buying Here – https://www.factmr.com/connectus/sample?flag=EB&rep_id=1001

The Report Covers Exhaustive Analysis On:

  • Rheumatoid Arthritis Stem Cell Therapy Market Drivers, Segments and Restraints.
  • Rheumatoid Arthritis Stem Cell Therapy Market Survey and Dynamics
  • Rheumatoid Arthritis Stem Cell Therapy Market Size & Demand
  • Rheumatoid Arthritis Stem Cell Therapy Key Trends/Issues/Challenges
  • Rheumatoid Arthritis Stem Cell Therapy Sales, Competition & Companies involved

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Slide Processing System Market Is Expected To Witness Significant Demand And Higher Sales By End Of Assessment Year 2031

Slide Processing System automates the denaturation and hybridization steps in slide-based fluorescent in situ hybridization (FISH) assays, and provides walk-away convenience for clinical and research laboratory personnel.

The slide processing system processes as many as 12 slides at once, and does not need to be fully loaded to maintain temperature accuracy. Additionally, the instrument offers temperature uniformity and heats slides to temperatures ideal for FISH procedures. These characteristics aid in the high acceptance of slide processing system by end users.

Request For Sample –  https://www.factmr.com/connectus/sample?flag=S&rep_id=998

Slide Processing System Market: Drivers and Restraints

Increasing number of surgical procedures is one of the key factors driving the demand for slide processing system in hospitals, surgical centers, and emergency rooms. Furthermore, the technological advancement of slide processing system is another factor which is propelling the slide processing system market. With regards to this, the system is featured with the following added advantages, such as elimination of manual steps and reduction of hands-on time during (FISH) procedures. The slides do not have to be fully loaded to maintain temperature accuracy, also slide guide keeps the slides in place and allows for one hand removal.

Moreover, the added advantages of the slide processing system is also boosting the demand for the system by the end users. For instance, the system accepts a range of sample types and reduces hands-on time while ensuring precision and accuracy in (FISH) assays. Besides, the system heats slides to temperatures ideal for (FISH) procedures, and the lid seals tightly when closed, allowing for optimal chamber humidity However, the high cost of the system is the only major factor that is restraining the growth of the slide processing system market.

Slide Processing System Market: Regional Outlook

Geographically, the global slide processing system market is segmented into regions, namely North America, Latin America, Europe, Asia Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be a leading market in the global slide processing system market owing to growing demand and increasing number of end users. The market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to increasing number of academic institutes and researches. Europe is expected to have second large share in the global slide processing system market throughout the forecast period.

Request Customized Report as Per Your Requirements https://www.factmr.com/connectus/sample?flag=RC&rep_id=998

Slide Processing System Market: Key Participants

The global market for slide processing system is highly consolidated and dominated by few players. The manufacturers present in this market offers the technologically advanced slide processing system, globally. Some of the major players operating in the global slide processing system market are Leica Biosystems Nussloch GmbH, Abbott Laboratories and Advanced Cell Diagnostics, Inc. These major players hold the maximum share of the market.

Slide Processing System Market: Segmentation

The global slide processing system market can be segmented on the basis of end users.

Based on end users, the global slide processing system market is segmented as:

  • Biotechnology and Pharmaceuticals Companies
  • CROs
  • Private Laboratories
  • Academic Institutes
  • Others

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand For Veterinary Wound Spray Is Likely To Grow In The Emerging Economies Owing To Rising Pet Ownerships, Unveils Fact.MR

The veterinary wound spray market is expected to witness significant growth on the back of growing pet ownerships coupled with increasing pet wounds across the globe. The demand for veterinary wound spray is likely to grow in the emerging economies owing to rising pet ownerships.

For instance, according to IIPTF (India International Pet Trade Fair) around 600,000 pets are adopted in India annually. In addition, the veterinary wound spray market continues to remain influenced with a combination of industry-specific and macroeconomic aspects such as economic stability, GDP per capita and growing purchasing power parity across nations.

Request for Sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=997

Veterinary Wound Sprays Market: Segmentation

Tentatively, the global veterinary wound sprays market can be segmented on the basis of product type, animal type, distribution channel, and geography.

Based on product type, the global veterinary wound sprays market is segmented as:

  • Wetting Agents
  • Antiseptics
  • Moisturizers
  • Others

Based on animal type, the global veterinary wound sprays market is segmented as:

  • Canine
  • Feline
  • Bovine
  • Craps
  • Poultry
  • Equine
  • Others

Based on distribution channel, the global veterinary wound sprays market is segmented as:

  • Veterinary Clinics
  • Veterinary Pharmacies
  • E-commerce

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=997

Veterinary Wound Sprays Market: Key Players

Examples of some of the key players operating in the global veterinary wound sprays market are Innovacyn, Inc., Fauna Care LLC, EquiSilver LLC, Biomir Venture LLP, Zoetis, Inc, Vetoquinol, Virbac, Neogen Corporation, Bayer AG, etc.

Veterinary Wound Sprays Market: Regional Outlook

Geographically, the global veterinary wound sprays market is segmented into viz. North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to gain maximum market share in terms of revenue owing to increased veterinary care spending.

North America is followed by Western Europe and Latin America due to increased pet adoption in these regions. Asia-Pacific excluding Japan is expected to grow at faster rate than the other regions due to rising pet adoption. Middle East and Africa is expected show delayed growth due to lack of availability of veterinary doctors in the region.

Essential Takeaways from the this Market Report

  • Comparison of prominent players operating in the market.
  • Recent developments and key strategies adopted by key players.
  • Study of the micro and macro-economic growth indicators.
  • Impact of the various factors on the value chain.
  • Evaluation of current Veterinary Wound Sprays market size, forecast and technological advancements within the industry.
  • Current Insights influencing the scenario and key trends in Veterinary Wound Sprays market.

Enquire Before Buying Here – https://www.factmr.com/connectus/sample?flag=EB&rep_id=997

The Report Covers Exhaustive Analysis On:

  • Veterinary Wound Sprays Market Drivers, Segments and Restraints.
  • Veterinary Wound Sprays Market Survey and Dynamics
  • Veterinary Wound Sprays Market Size & Demand
  • Veterinary Wound Sprays Key Trends/Issues/Challenges
  • Veterinary Wound Sprays Sales, Competition & Companies involved

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com